Commitments and Contingencies

12 Months Ended

Dec. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

14. Commitments and Contingencies

Leases

The Company’s primary lease represents the lease for its corporate headquarters in Boston, Massachusetts. The Company modified the corporate headquarter lease during the third quarter of 2021. Rent expense for the years ended December 31, 2024, 2023 and 2022 was $3,746, $4,292 and $4,967. The carrying value of the Company’s right-of-use assets are substantially concentrated in real estate as the Company primarily leases office space. The Company’s policy is not to record leases with an original lease term of one year or less on the consolidated balance sheets. The Company recognizes lease expense for these short-term leases on a straight-line basis over the lease term. The Company does not have any lease contracts with the option to purchase as of December 31, 2024.


	Years Ended December 31,
	2024		2023		2022
The components of lease cost under ASC 842 were as follows:
Operating lease cost	$	3,390	$	3,495	$	3,694
Short-term lease cost		—		—		—
Variable lease cost		—		—		—
Total lease cost	$	3,390	$	3,495	$	3,694


	Years Ended December 31,
	2024		2023		2022
Supplemental cash flow information:
Cash paid for amounts included in measurement of lease liabilities:
Operating cash flows from operating leases	$	3,690	$	3,527	$	2,672
Non-cash lease activity:
Right-of-use lease assets obtained in exchange for new operating lease liability:
Operating leases	$	—	$	—	$	851


	As of December 31,
	2024			2023
Supplemental balance sheet information related to leases is as follows:
Operating leases
Operating lease right-of-use assets	$	7,203		$	10,453
Total operating right-of-use lease assets	$	7,203		$	10,453
Operating lease liabilities, current		3,690			3,580
Operating lease liabilities, net of current portion		4,511			8,206
Total operating lease liabilities	$	8,201		$	11,786
Weighted-average remaining lease term (in years)	2.2 years			3.2 years
Weighted-average discount rate		1.2	%		1.2	%

As of December 31, 2024, minimum future lease payments for these operating leases were as follows:


Years ending December 31,
2025	3763
2026	3647
2027	893
2028		—
2029		—
Thereafter		—
Total lease payments	$	8,303
Less imputed interest		(102	)
Total present value of lease liabilities	$	8,201

Indemnification

The Company’s arrangements generally include certain provisions for indemnifying clients against third-party claims asserting infringement of certain intellectual property rights in the ordinary course of business. The Company also regularly indemnifies clients against third-party claims that the company’s products or services breach applicable law or regulation or from claims resulting from a breach of the business associate agreement in place with the client. In addition, the Company indemnifies its officers, directors and certain key employees while they are serving in good faith in their capacities. Through December 31, 2024, there have been no claims under any indemnification provisions.

Litigation

From time to time, and in the ordinary course of business, the Company may be subject to various claims, charges, and litigation. On September 14, 2020, the Company received a letter from Teladoc Health, Inc. alleging that certain of the Company’s cart products and associated peripherals infringe upon their patents. On October 12, 2020, Teladoc Health, Inc filed a claim against the Company related to these allegations. On June 30, 2022, the claim was dismissed pursuant to a confidential settlement between the parties. As of December 31, 2024 and 2023, the Company did not have any pending claims, charges or litigation that it expects would have a material adverse effect on its consolidated financial position, results of operations or cash flows.